TREA

87736059 - HEP X

Follow

Information

  • Trademark
  • 87736059
  • Serial Number
    87736059
  • Registration Number
    5742579
  • Filing Date
    December 27, 2017
    6 years ago
  • Registration Date
    May 07, 2019
    5 years ago
  • Transaction Date
    May 07, 2024
    7 months ago
  • Status Date
    May 07, 2019
    5 years ago
  • Published for Opposition Date
    January 01, 2019
    5 years ago
  • Location Date
    May 07, 2019
    5 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    BUTTON, JENNIFER JO
  • Attorney Docket Number
    128026-90801
    Attorney Name
    Margarita Wallach
    Law Office Assigned Location Code
    L50
  • Owners
Information
Mark Drawing Code
4
Mark Identification
HEP X
Case File Statements
  • GS0051: Pharmaceutical preparations for use in the field of 3D bio-printing of tissues and organs; Preparations based on cellulous nano-fibrils for use in the 3D bio-printing of tissues and organs; Tissue-regenerative pharmaceutical preparations; Cells for medical use; Human allograft tissue; Living cells for medical use; Implants of living tissues for guided tissue regeneration; Implants comprising living tissue; Implantable materials of living tissue for use in guided tissue regeneration; Skin grafts; Surgical implants comprised of living tissues; Surgical implants of living tissues grown from stem cells; Transdermal patches for use to create skin for prosthetic limbs and for skin grafts; Living tissues for transplant; Engineered biological tissues and organs, namely, human and animal cardiovascular, pulmonary, digestive, hepatobiliary, urological, renal, endocrine, connective, epithelial, muscular, and nervous tissue and organs, for medical purposes; Biological molecules to assist in the development of tissue; Haemostatic gel matrix preparations for treating wounds; Natural biomaterials for augmentation of bone, blood and tissue for medical purposes; Pharmaceutical products for tissue regeneration, for tissue repair, for tissue treatment, whether relating to human or animal tissue; Pharmaceutical preparations for the treatment of bone diseases, for cartilaginous diseases, for vascular diseases, for neuronal degeneration, for degeneration of tendons and ligaments, for retinal degeneration, for renal degeneration, degeneration of soft tissue, for diseases with abnormal cell proliferation; Natural biomaterials for bone filling; Natural biomaterials for filling cartilage; Biological tissue cultures for medical use; Biological tissue cultures for medical purposes; Biological tissue grafts; Biological bone and skin tissues impregnated with lines of oxygen for tissue engineering applications to increase cell survival in tissue intended for subsequent implantation; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Implantable scaffolds comprising living tissue for maintaining tissue contour; Implants comprising living tissue; Natural biomaterials for augmentation of bone and tissue for medical purposes
  • GS0011: Biologically compatible polymers, namely, hydrogels used to manufacture polymeric networks used in the manufacture of engineered living tissue for medical, scientific and non-scientific purposes; Media for cell culture for use in the biotechnological industry; Media for cell culture for use in non-medical research laboratories; Biological preparation for use in cell cultures other than for medical or veterinary use; Engineered biological tissues and tissue arrays, namely, human and animal organ, connective, epithelial, muscular, and nervous tissues and tissue arrays, for use in scientific and medical research; Biologically compatible materials, namely, hydrogels used to create polymeric networks used in the manufacture of living tissue; Proteins in raw material form for scientific and medical research
Case File Event Statements
  • 1/12/2018 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 12/30/2017 - 6 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 4/6/2018 - 6 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/9/2018 - 6 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/9/2018 - 6 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/9/2018 - 6 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/9/2018 - 6 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/28/2018 - 6 years ago
    12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/12/2018 - 6 years ago
    13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 10/9/2018 - 6 years ago
    8 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/18/2018 - 6 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 10/29/2018 - 6 years ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/29/2018 - 6 years ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/1/2019 - 5 years ago
    15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/15/2019 - 5 years ago
    19 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN
  • 4/2/2019 - 5 years ago
    18 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 1/1/2019 - 5 years ago
    14 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/26/2019 - 5 years ago
    16 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 3/15/2019 - 5 years ago
    17 - TEAS DELETE 1(B) BASIS RECEIVED Type: D1BR
  • 4/2/2019 - 5 years ago
    20 - 1(B) BASIS DELETED; PROCEED TO REGISTRATION Type: DP1B
  • 5/7/2019 - 5 years ago
    21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 2/15/2023 - a year ago
    22 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 5/7/2024 - 7 months ago
    23 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1